Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Advances in Urology
|
January 7, 2009
BPH procedural treatment: the case for value-based pay for performance
Mark Stovsky, Irina Jaeger
The Journal of Urology
|
July 24, 2010
Testicular plasmacytoma
Youssef Tanagho, Mark Stovsky, Gregory T Maclennan
Urology Practice
|
May 5, 2023
Decision Analysis Model Comparing Cost of IsoPSA™ vs Repeat Biopsy for Detection of Clinically Significant Prostate Cancer in Men with Previous Negative Findings on Biopsy
Yair Lotan, Mark Stovsky, Robert Rochelle, et al.
Urology
|
June 9, 2022
Elevated IsoPSA Selects for Clinically Significant Prostate Cancer Without a Preference for Any Particular Adverse Histopathologic or Radiographic Feature
Tarik Benidir, Martin Hofmann, Zaeem Lone, et al.
Urology
|
July 26, 2011
Prostate-specific antigen/solvent interaction analysis: a preliminary evaluation of a new assay concept for detecting prostate cancer using urinary samples
Mark Stovsky, Lee Ponsky, Srinivas Vourganti, et al.
Urologic Oncology
|
July 15, 2022
Clinical validation of IsoPSA, a single parameter, structure-focused assay for improved detection of prostate cancer: A prospective, multicenter study
Eric A Klein, Alan Partin, Yair Lotan, et al.
European Urology
|
April 12, 2017
The Single-parameter, Structure-based IsoPSA Assay Demonstrates Improved Diagnostic Accuracy for Detection of Any Prostate Cancer and High-grade Prostate Cancer Compared to a Concentration-based Assay of Total Prostate-specific Antigen: A Preliminary Report
Eric A Klein, Arnon Chait, Jason M Hafron, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 16, 2016
Dose-Escalated Stereotactic Body Radiation Therapy for Patients With Intermediate- and High-Risk Prostate Cancer: Initial Dosimetry Analysis and Patient Outcomes
Rupesh Kotecha, Toufik Djemil, Rahul D Tendulkar, et al.
Urology
|
February 22, 2023
IsoPSA Performance Characteristics are Unaffected by 5-Alpha Reductase Inhibitors or Alpha-Blockers: Results From the IsoPSA Validation Study
Jason M Scovell, Mark Stovsky, Alan Partin, et al.
American Journal of Clinical Oncology
|
April 30, 2020
Heterogenous Dose-escalated Prostate Stereotactic Body Radiation Therapy for All Risk Prostate Cancer: Quality of Life and Clinical Outcomes of an Institutional Pilot Study
Shireen Parsai, Aditya Juloori, Geoffrey Sedor, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Advances in Urology
|
January 7, 2009
BPH procedural treatment: the case for value-based pay for performance
Mark Stovsky, Irina Jaeger
The Journal of Urology
|
July 24, 2010
Testicular plasmacytoma
Youssef Tanagho, Mark Stovsky, Gregory T Maclennan
Urology Practice
|
May 5, 2023
Decision Analysis Model Comparing Cost of IsoPSA™ vs Repeat Biopsy for Detection of Clinically Significant Prostate Cancer in Men with Previous Negative Findings on Biopsy
Yair Lotan, Mark Stovsky, Robert Rochelle, et al.
Urology
|
June 9, 2022
Elevated IsoPSA Selects for Clinically Significant Prostate Cancer Without a Preference for Any Particular Adverse Histopathologic or Radiographic Feature
Tarik Benidir, Martin Hofmann, Zaeem Lone, et al.
Urology
|
July 26, 2011
Prostate-specific antigen/solvent interaction analysis: a preliminary evaluation of a new assay concept for detecting prostate cancer using urinary samples
Mark Stovsky, Lee Ponsky, Srinivas Vourganti, et al.
Urologic Oncology
|
July 15, 2022
Clinical validation of IsoPSA, a single parameter, structure-focused assay for improved detection of prostate cancer: A prospective, multicenter study
Eric A Klein, Alan Partin, Yair Lotan, et al.
European Urology
|
April 12, 2017
The Single-parameter, Structure-based IsoPSA Assay Demonstrates Improved Diagnostic Accuracy for Detection of Any Prostate Cancer and High-grade Prostate Cancer Compared to a Concentration-based Assay of Total Prostate-specific Antigen: A Preliminary Report
Eric A Klein, Arnon Chait, Jason M Hafron, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 16, 2016
Dose-Escalated Stereotactic Body Radiation Therapy for Patients With Intermediate- and High-Risk Prostate Cancer: Initial Dosimetry Analysis and Patient Outcomes
Rupesh Kotecha, Toufik Djemil, Rahul D Tendulkar, et al.
Urology
|
February 22, 2023
IsoPSA Performance Characteristics are Unaffected by 5-Alpha Reductase Inhibitors or Alpha-Blockers: Results From the IsoPSA Validation Study
Jason M Scovell, Mark Stovsky, Alan Partin, et al.
American Journal of Clinical Oncology
|
April 30, 2020
Heterogenous Dose-escalated Prostate Stereotactic Body Radiation Therapy for All Risk Prostate Cancer: Quality of Life and Clinical Outcomes of an Institutional Pilot Study
Shireen Parsai, Aditya Juloori, Geoffrey Sedor, et al.
Page
of 2